Open AccessDifferent doses of consensus interferon plus ribavirin in patients with hepatitis C virus genotype 1 relapsed after interferon monotherapy: A randomized controlled trial
Author(s) -
Giuseppe Alaimo,
V. Di Marco,
Donatella Ferraro,
R. Di Stefano,
Salvatore Porrovecchio,
Francesca D’Angelo,
V. Calvaruso,
Piero Luigi Almasio
Publication year - 2006
Publication title -
world journal of gastroenterology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.427
H-Index - 155
eISSN - 2219-2840
pISSN - 1007-9327
DOI - 10.3748/wjg.v12.i42.6861
Subject(s) - ribavirin , medicine , gastroenterology , randomized controlled trial , group b , adverse effect , interferon , group a , hepatitis c virus , alpha interferon , combination therapy , immunology , virus
To assess the efficacy of different schedules of consensus interferon (CIFN) plus ribavirin in retreating chronic hepatitis C patients who relapsed after recombinant interferon (rIFN) monotherapy.